FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough
STOCK PHOTO/Getty Images
(WASHINGTON) — Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday.
The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and older.
The new shot is an alternative to treatments that usually need to be given every month or every few months.
“Fluralaner, the active ingredient in Bravecto Quantum, can be an important part of parasite control depending on where pet owners live in the country,” said Dr. Tina Wismer, senior director of toxicology at ASPCA Poison Control, in an email to ABC News. “A long-term flea and tick preventative can be a useful option for dog owners who live in areas where year-round protection is necessary, or for those who might not be able or remember to administer treatment on a monthly or quarterly basis.”
The injectable treatment must be administered by a licensed veterinarian, who will determine whether an 8- or 12-month protection period is appropriate based on local tick species. Veterinarians will also monitor for potential side effects.
While the drug belongs to a commonly used and safe class of medications called isoxazolines, some dogs may experience neurologic side effects, including muscle tremors and seizures.
Julie Cappiello, with Voters For Animal Rights, an advocacy organization, said she welcomes the new treatment but emphasized caution.
“As someone who spends a great deal of time outdoors with my dog, I see the convenience of a long-lasting, 12-month flea and tick preventative like Bravecto Quantum,” she said in a statement. “However, it’s important to recognize that no single treatment is right for every dog, and all medications come with potential risks.”
The new treatment is manufactured by Intervet, Inc., based in Rahway, New Jersey.
Pet owners interested in the new treatment option should consult their veterinarians to determine if it’s appropriate for their dogs, particularly those with a history of neurological issues.
Plexi Images/GHI/UCG/Universal Images Group via Getty Images
(NEW YORK) — The U.S. Food and Drug Administration expanded its approval of Moderna’s respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the disease.
Previously, the vaccine, known as mRESVIA, had been licensed for use for those aged 60 and older.
Approval for mRESVIA came after Moderna conducted a late-stage clinical trial showing the vaccine helped boost immune responses in younger adults.
More than one-third of adults between ages 18 and 59 have at least one underlying condition that puts them at increased risk of RSV, according to Moderna.
“RSV poses a serious health risk to adults with certain chronic conditions, and today’s approval marks an important step forward in our ability to protect additional populations from severe illness from RSV,” Stéphane Bancel, CEO of Moderna, said in a press release. “We appreciate the FDA’s review and thank all the participants in our clinical trial as well as the Moderna team for their dedication to protecting people against RSV.”
Although the FDA approves vaccines and may expand approvals for certain age groups, the Centers for Disease Control and Prevention sets recommendations regarding who should get vaccines and when.
Currently, the CDC recommends RSV vaccination only for those aged 75 and older and for those aged 60 and over at increased risk.
The CDC’s independent vaccine advisory committee will need to vote to recommend that the new age group be eligible for the shot, followed by a final recommendation from the director of the CDC.
Earlier this week, Kennedy removed all 17 sitting members of the committee and replaced them with eight new members. It remains unclear how the new members of the panel will decide to approach recommendations for the RSV vaccine.
As of Friday, the CDC director role remains vacant and Health and Human Services Secretary Robert F. Kennedy Jr. has been making final recommendations. In an April meeting, the prior advisory committee voted to recommend RSV vaccination for those aged 50 to 59 with increased risk of disease, but Kennedy did not adopt the recommendations.
Instead, it appears Kennedy plans to have the new committee re-discuss the recommendations for RSV vaccination as well as discuss HPV and COVID vaccinations in their meeting scheduled to be held between June 25 and June 27
Moderna’s RSV vaccine is based on mRNA technology, which some of the new members have expressed skepticism about, especially in relation to COVID-19 vaccines.
Despite availability, RSV vaccination has been lagging. As of April 26, the latest date for which CDC data is available, an estimated 47.5% of adults aged 75 and older and 38.1% of adults aged 60 to 74 with a high-risk condition reported ever having received an RSV vaccine.
Myung J. Chun / Los Angeles Times via Getty Images
(BAKERSFIELD, CA) — A 4-year-old girl receiving “lifesaving medical treatment” in the United States was granted humanitarian parole for one year, allowing her and her mother to remain in the country, the child’s attorneys announced on Tuesday.
The child and her mother, Deysi Vargas, have been living in the U.S. since 2023, but received three letters from the Department of Homeland Security in April saying their humanitarian parole was being terminated.
The young girl — who is identified by her lawyers under the pseudonym “Sofia” — suffers from “short bowel syndrome,” which prevents her from being able to properly absorb nutrients and fluid from food on her own.
Vargas received official notice from U.S. Citizenship and Immigration Services (USCIS) on Tuesday that she and her daughter were granted humanitarian parole. The parole period will last for exactly one year, expiring on June 1, 2026.
The legal victory came after Vargas brought Sofia for a biometrics appointment at a USCIS field office in Bakersfield, California, on May 30.
“We are profoundly grateful that USCIS acted swiftly to grant Sofia and her mother one year of humanitarian parole. By moving quickly, the agency has ensured that a four‑year‑old girl can continue receiving her life-saving medical treatment. We commend USCIS for its responsiveness and for recognizing the urgency of this situation,” her lawyers at Public Counsel said in a statement.
Sofia began receiving life-saving medical treatment for this condition at Children’s Hospital Los Angeles when she and her parents crossed the border from Mexico in 2023 on humanitarian parole, Sofia’s lawyers said during a press conference in May.
Sofia’s medical care, which consists of her receiving specialized IV treatments for up to 14 hours a day, can only be administered in the United States, per the equipment manufacturer, her lawyers said.
Vargas said the treatment in the U.S. has allowed Sofia to “live her life” with her family, but if she and her daughter were forced to return back to Mexico, Sofia “will be at the hospital day and night,” she said during the press conference.
In their statement on Tuesday, Sofia’s attorneys said, “While we celebrate this victory, we cannot ignore the systemic challenges that brought Sofia to the brink. Her parole was terminated without warning, and for weeks there was no functional avenue to alert USCIS that a child’s life was in danger. It took an international outcry and pressure from elected officials to get a response — something that used to take a single phone call.”
“Our immigration system must protect everyone facing life‑threatening harm. We cannot let this country turn its back on our immigrant neighbors seeking safety, justice, and a fair chance at life,” her attorneys said.
ABC News’ Matt Claiborne and Megan Forrester contributed to this report.
Kat Cisar and her six-year-old twins, who attend a Milwaukee school that was found to have hazardous lead in the building. (ABC News)
(MILWAUKEE) — Kat Cisar, a mother of 6-year-old twins, found out in late February that her kids were potentially being exposed to harmful lead paint and dust at their Milwaukee school. By May, their school was on a growing list of eight others across the city, found to have degrading, chipping interiors that were putting children at risk.
Several schools have had to temporarily close for remediation efforts, including the one Cisar’s kids attend.
“We put a lot of faith in our institutions, in our schools, and it’s just so disheartening when those systems fail,” Cisar said.
Milwaukee’s lead crisis began late last year, when a young student’s high blood lead levels were traced back to the student’s school.
Since then, health officials have been combing through other Milwaukee schools to find deteriorated conditions that could harm more children. The plan now is to inspect roughly half of the district’s 106 schools built before 1978 — when lead paint was banned — in time for school to return in the fall. They plan to inspect the other half before the end of the year.
In the last few months, tests have turned up elevated blood lead levels in at least three more students, and the health department expects that number to grow as it continues to offer free testing clinics around the city.
Lead exposure — especially harmful for young children — can cause growth delays, attention disorders and even brain damage, according to the Centers for Disease Control and Prevention (CDC).
Cisar’s own children’s tests for lead levels showed no acute poisoning, but Cisar said they’ll have to keep monitoring it. Her children attended the school for three years.
“When you have little kids who are 3, 4, 5, 6 years old in a classroom like that, that’s worrisome,” she said.
The local impacts of federal cuts
Despite public health officials’ requests, federal help is not coming to Milwaukee — for now. The CDC’s National Center for Environmental Health was gutted on April 1, as part of the Trump administration’s effort to lay off 10,000 employees at the Health and Human Services Department (HHS), which oversees agencies like FDA and CDC.
The cuts included lead exposure experts who were planning to fly to Milwaukee later that month to help the city respond to the situation.
That has complicated the on-the-ground response, Milwaukee Commissioner of Health Mike Totaraitis told ABC News.
“We rely on the federal government for that expertise,” Totoraitis said. “So to see that eliminated overnight was hard to describe, to say the least.”
Erik Svendsen, division director of the CDC’s National Center for Environmental Health before it was eliminated, said the layoffs have left Milwaukee on its own.
“Without us, there is no other unit at the federal level that is here to support them in doing what they need to do,” Svendsen told ABC News.
And not just when it comes to this lead crisis, Svendsen said. Milwaukee — and other cities — won’t have CDC assistance for other environmental threats that affect the buildings people use, the air people breathe and the water they drink, he said.
“States and local public health departments are on their own now as we prepare for the heat, wildfire, algal bloom, tornado, flood and hurricane seasons,” Svendsen said.
An HHS spokesperson told ABC News the CDC’s lead prevention work will be consolidated under a new division under HHS Secretary Robert F. Kennedy Jr. — though Svendsen said he and his team have not been rehired.
Without the experts, Svendsen said the future of the work is still in limbo.
For his part, Totoraitis, the Milwaukee health commissioner, said he empathizes with the frustration expressed by parents — some of whom argue that the issue began at a local level and should be solved there.
“Putting my feet in the parents’ shoes… thinking, ‘Hey, I’m sending my kid to school, it should be safe, it should be free of lead hazards’ — and unfortunately, that’s not what we found,” Totoraitis said.
“We found that systemic issues of poor maintenance and poor cleaning had left countless hazards across multiple schools that really put students at danger,” he said.
But the extent of the problem, Totoraitis said, only furthered his department’s reliance on the experts at the CDC, with whom he said they’d been constantly in contact with for the last few months.
Funding crunch: Hire more teachers or paint a wall?
Buildings in the U.S. built before 1978 can be properly maintained by locking the old paint under layers of fresh new paint. But budget constraints in Milwaukee delayed that upkeep, officials said.
“Underfunding in schools for many, many years has really put districts at a very difficult choice of whether they should have teachers in the classroom and lower class sizes or have a paraprofessional to support — or whether they paint a wall,” said Brenda Cassillius, who started as Milwaukee Public Schools superintendent one month ago.
“And so I think now we are learning and growing,” Cassillius said, to “make sure that we have the resources in place to deal with these really serious infrastructure issues.”
Cisar, whose twins are back at their school after cleanup efforts, said she still feels like there’s lots of blame to go around.
The lack of CDC resources, she said, has only compounded a longstanding issue in Milwaukee. But she said the lack of federal support has been disheartening, nonetheless.
“Maybe that would have just been a little bit of help — but it really sends the message of, ‘You don’t matter,'” she said.
